Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

essential medicines

- PMLiVE

India revokes Pfizer’s patent on Sutent

Loses patent protection for kidney cancer drug after Cipla and Natco challenge

- PMLiVE

MSF unveils website to help pharma patent challengers

Patent Opposition Database contains patents facing opposition

- PMLiVE

Indian drug price cuts up for Cabinet approval

Aims to expand access to medicines in one of world’s fastest growing markets

- PMLiVE

Indian online doctor community supported by new patient portal

Medigrity Innovations' eMedWorld information site 'tightly integrated' with its physician community DocLynk

- PMLiVE

Roche loses Indian Tarceva patent battle with Cipla

As Novartis' Glivec patent law challenge begins again

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links